82.45
price up icon1.10%   0.90
after-market Dopo l'orario di chiusura: 82.45
loading

Inhibrx Biosciences Inc Azioni (INBX) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-09-30 2025-07-01 2025-03-31 2024-12-31 2024-09-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - 0.10 -
Operating Expenses
33.81
- 42.90 50.03 46.80
Operating Income/Loss
-33.81
- -42.90 -49.93 -46.80
Nonoperating Income/Loss
-1.444
- -0.41 2.063 2.933
Income/Loss From Continuing Operations Before Tax
23.04%
-35.26
-28.65 -43.31 -47.87 -43.86
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
23.04%
-35.26
-28.65 -43.31 -47.87 -43.86
Net Income/Loss
23.04%
-35.26
-28.65 -43.31 -47.87 -43.86
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
15.48
- 15.47 0.224 15.47
Diluted Average Shares
15.48
- 15.47 0.163 15.47
Basic Earnings Per Share
-2.28
- -2.80 -5.03 -2.84
Diluted Earnings Per Share
-2.28
- -2.80 -4.47 -2.84
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$91.09
price up icon 1.97%
$118.87
price up icon 1.02%
$34.72
price down icon 0.83%
$58.73
price down icon 0.17%
ONC ONC
$325.90
price up icon 0.00%
$278.40
price up icon 2.44%
Capitalizzazione:     |  Volume (24 ore):